Perjeta/Herceptin (pertuzumab/trastuzumab)

pCPA File Number: 21087
Negotiation Status:
Negotiations were not pursued
Indication(s):
early breast cancer
Sponsor/Manufacturer:
Hoffmann-La Roche
CDA-AMC Project Number:
pCODR 10127
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: